liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Platelet thrombin receptors PAR1 and PAR4 act in a synergistic manner
Linköping University, Department of Clinical and Experimental Medicine, Clinical Chemistry. Linköping University, Faculty of Health Sciences.
Linköping University, Department of Clinical and Experimental Medicine, Division of Microbiology and Molecular Medicine. Linköping University, Faculty of Health Sciences.
Linköping University, Department of Clinical and Experimental Medicine, Clinical Chemistry. Linköping University, Faculty of Health Sciences.
Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.ORCID iD: 0000-0002-1920-3962
Show others and affiliations
(English)Manuscript (preprint) (Other academic)
Abstract [en]

n/a

National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-51932OAI: oai:DiVA.org:liu-51932DiVA: diva2:278161
Available from: 2009-11-24 Created: 2009-11-24 Last updated: 2015-03-13Bibliographically approved
In thesis
1. The role of platelet thrombin receptors PAR1 and PAR4 in platelet activation
Open this publication in new window or tab >>The role of platelet thrombin receptors PAR1 and PAR4 in platelet activation
2009 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Platelets play a pivotal role in coagulation and haemostasis. Their most prominent task is to seal damaged blood vessels by the formation of a platelet plug at the damaged area. Once the injury is covered, platelets retract the coagulum to close the wound and allow the blood to flow freely in the vessel. Platelets are strongly activated by the essential enzyme thrombin, formed in the coagulation cascade. Activation of the platelet thrombin receptors PAR1 and PAR4 leads to shape change, secretion of granule content, and aggregation, all of which can be accomplished by each receptor individually. However more and more findings indicate that there are differences between the receptors and that they have different physiological functions.

This thesis presents studies performed to elucidate the relative role of PAR1 and PAR4 in platelet activation and coagulation.

We have studied the effects on platelet activation and coagulation, and revealed a possible physiological role for PAR4 in the stabilisation of the coagulum. We also investigated the relative role of PAR1 and PAR4 in the cross-talk between thrombin and epinephrine with and without inhibition of COX-1. We demonstrated that PAR4 interacts with adrenergic receptors and causes an aggregation of platelets dependent on released ATP and its receptor P2X1, thereby circumventing the inhibition by aspirin. Not only is this an interesting specific role for PAR4, but it may also be of clinical importance considering that COX-1 inhibition is the most common treatment for patients with cardiovascular disease to prevent thrombosis.

We show that the number of PAR1 receptors varied between donors and that this variation was correlated to the response on receptor activation. The number of PAR1 receptors on the platelet surface was decreased after PAR1 stimulation but increased after stimulation of other receptors.

In a final attempt to elucidate the nature of PAR1 and PAR4 we used mathematics to evaluate the effect of co-stimulation of the receptors. We found a strong synergistic effect for both platelet activation and aggregation. This indicates that PAR1 and PAR4 interact in a yet unknown way to regulate or amplify the effect of each other rather than merely transmitting the incoming signal the same way.

Place, publisher, year, edition, pages
Linköping: Linköping University Electronic Press, 2009. 70 p.
Series
Linköping University Medical Dissertations, ISSN 0345-0082 ; 1156
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-51935 (URN)978-91-7393-505-0 (ISBN)
Public defence
2009-12-04, Linden, Hälsouniversitetet, Campus US, Linköpings Universitet, Linköping, 13:00 (English)
Opponent
Supervisors
Available from: 2009-11-24 Created: 2009-11-24 Last updated: 2015-03-13Bibliographically approved

Open Access in DiVA

No full text

Other links

Link to Ph.D. Thesis

Authority records BETA

Vretenbrant Öberg, KarinBoknäs, NiklasKalsum, SadafRamström, SofiaLindahl, Tomas

Search in DiVA

By author/editor
Vretenbrant Öberg, KarinBoknäs, NiklasKalsum, SadafRamström, SofiaLindahl, Tomas
By organisation
Clinical ChemistryFaculty of Health SciencesDivision of Microbiology and Molecular MedicineDepartment of Clinical Chemistry
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 87 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf